The role of eNOS gene polymorphisms on contrast induced nephropathy development in chronic kidney disease patients

被引:0
|
作者
Kilic, Ilhan [1 ]
Palabiyik, Orkide [2 ]
Kurultak, Ilhan [3 ]
Sipahi, Tammam [2 ]
Ustundag, Sedat [3 ]
机构
[1] Edirne Sultan 1 Murat State Hosp, Nephrol Dept, Fatih St, TR-22030 Edirne, Turkey
[2] Trakya Univ, Biophys Dept, Edirne, Turkey
[3] Trakya Univ, Nephrol Dept, Edirne, Turkey
关键词
chronic kidney disease; contrast nephropathy; gene polymorphism; NITRIC-OXIDE PRODUCTION; PATHOGENESIS; ASSOCIATION; PROTEINS;
D O I
10.1111/1744-9987.13921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Contrast nephropathy is a result of contrast media given through intravascular routes. Nitric oxide gene polymorphisms may alter the hemodynamic stability resulting in medullary ischemia Nitric oxide gene polymorphisms may have an enhancing role in contrast media related renal injury. The aim of this study was to investigate the role of eNOS intron 4a/b, T786C, and G894T gene polymorphisms on contrast-nephropathy risk. Methods Ninety-four chronic kidney disease patients with contrast nephropathy and 120 chronic kidney disease patients without contrast nephropathy were included. DNA isolation was performed and specific regions of DNA for eNOS G894T, T786C, and intron 4a/b genes were amplified by polymerase chain reaction technique. Results TT polymorphism of T786C gene and GG polymorphism of G894T gene were detected to be possibly protective from contrast induced nephropathy. Conclusion Endothelial nitric oxide synthase G894T gene polymorphisms, older age, and presence of diabetes mellitus may influence contrast nephropathy development.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 50 条
  • [31] Contrast nephropathy in patients with chronic kidney disease undergoing either diagnostic or interventional procedures
    Moreyra, Abel E.
    Natarajan, Madhu
    Doucet, Serge
    Sharma, Samin K.
    Staniloae, Cezor S.
    Katholi, Richard E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 124L - 124L
  • [32] Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease
    Klarenbach, SW
    Pannu, N
    Tonelli, MA
    Manns, BJ
    CRITICAL CARE MEDICINE, 2006, 34 (04) : 1044 - 1051
  • [33] INCIDENCE OF CONTRAST INDUCED NEPHROPATHY IN KIDNEY TRANSPLANT PATIENTS
    Afonso Ramos, Sara
    Jimenez Martin, Carlos
    Lopez Oliva, Maria Ovidia
    Gonzalez Garcia, Maria Elena
    Santana Valeros, Maria Jose
    Santiago Hernando, Antonio
    Selgas Gutierrez, Rafael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [34] Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients
    Naohiro Osugi
    Susumu Suzuki
    Yohei Shibata
    Yosuke Tatami
    Shingo Harata
    Tomoyuki Ota
    Mutsuharu Hayashi
    Yoshinari Yasuda
    Hideki Ishii
    Atsuya Shimizu
    Toyoaki Murohara
    Clinical and Experimental Nephrology, 2017, 21 : 391 - 397
  • [35] Oral Hydration and Alkalinization is Noninferior to Intravenous Therapy for Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease
    Cho, Roy
    Javed, Nosheen
    Traub, Darren
    Kodali, Sobhan
    Atem, Folefac
    Srinivasan, Venkatraman
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2010, 23 (05) : 460 - 466
  • [36] Reduction in risk of contrast-induced nephropathy in patients with chronic kidney disease and diabetes mellitus by enhanced external counterpulsation
    Zeng, Chun-Mei
    Zhao, Yan-Mei
    Zhong, Xin-Jing
    Wu, Zi-Jia
    Bai, Jing
    Qiu, Shi-Yu
    Li, Yi-Yi
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [37] Impact of combination method with sodium bicarbonate and ascorbic acid to prevent contrast induced nephropathy for patients with chronic kidney disease
    Komiyama, K.
    Ashikaga, T.
    Kobayashi, Y.
    Fukamizu, S.
    Sakurada, H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 272 - 272
  • [38] Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients
    Osugi, Naohiro
    Suzuki, Susumu
    Shibata, Yohei
    Tatami, Yosuke
    Harata, Shingo
    Ota, Tomoyuki
    Hayashi, Mutsuharu
    Yasuda, Yoshinari
    Ishii, Hideki
    Shimizu, Atsuya
    Murohara, Toyoaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 391 - 397
  • [39] Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Karagiannis, Asterios
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (09) : 1059 - 1066
  • [40] THE CONTRAST VOLUME TO CREATININE CLEARANCE RATIO PREDICTS CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Guo, Xiaosheng
    Chen, Jiyan
    Liu, Yong
    Tan, Ning
    Zhou, Yingling
    Bei, Weijie
    Li, Hualong
    Chen, Shiqun
    Li, Liwen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1101 - 1101